Annual SG&A
$268.91M$16.85M-5.90%
Summary
- Current Value
- As of today, AGL annual SG&A is $268.91M, down -5.90% on
- Historical Performance
- AGL annual SG&A is down -37.10% over the past 3 years, and up +118.93% over the past 5 years
- All-Time High Comparison
- AGL annual SG&A is currently -37.10% below its historical high of $427.50M set on
- 3-Year Low Comparison
- AGL annual SG&A is +29.42% above its 3-year low of $207.79M reached on an earlier date
- Sector Comparison
- AGL annual SG&A is higher than 91.85% of companies in Healthcare sector
SG&A Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual SG&A | $268.91M | -5.9% | -37.1% | +118.9% | +118.9% | |
| Quarterly SG&A | $0.00 | -100.0% | -100.0% | -100.0% | -100.0% | |
| TTM SG&A | -$6.63B | -2521.2% | -3455.9% | -7289.8% | -10000.0% | |
| Price | $0.99 | -73.1% | -95.2% | – | – | |
| Annual Operating Expenses | $293.38M | -2.8% | -33.0% | +117.2% | +117.2% | |
| Annual Operating Profit | -$288.53M | -24.3% | +22.5% | -170.7% | -170.7% | |
| Annual D&A | $24.46M | +21.3% | +66.8% | -40.9% | -40.9% | |
| Annual Revenue | $6.06B | +40.4% | +230.5% | +662.9% | +662.9% |
SG&A Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $285.76M | -5.9% | |
| 5Y | $427.50M | -37.1% | |
| All | $427.50M | -37.1% |
SG&A Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $207.79M | N/A | +29.4% |
| 5Y | $137.29M | N/A | +95.9% |
| All | $122.83M | +118.9% |
SG&A History
| Year | Value | Change |
|---|---|---|
| $268.91M | -5.9% | |
| $285.76M | +37.5% | |
| $207.79M | -51.4% |
| Year | Value | Change |
|---|---|---|
| $427.50M | +211.4% | |
| $137.29M | +11.8% | |
| $122.83M | - |
FAQ
What is the current annual SG&A of AGL?
As of today, AGL annual SG&A is $268.91M
What is 1-year change in AGL annual SG&A?
AGL annual SG&A is down -5.90% year-over-year
What is 3-year change in AGL annual SG&A?
AGL annual SG&A is down -37.10% over the past 3 years
How far is AGL annual SG&A from its all-time high?
AGL annual SG&A is currently -37.10% below its historical high of $427.50M set on December 31, 2021
How does AGL annual SG&A rank versus sector peers?
AGL annual SG&A is higher than 91.85% of companies in Healthcare sector
When is AGL next annual earnings release?
The next annual earnings release for AGL is on
Quarterly SG&A
$0.00$56.28M-100.00%
Summary
- Current Value
- As of today, AGL quarterly SG&A is $0.00, down -100.00% on
- Historical Performance
- AGL quarterly SG&A is down -100.00% year-over-year, and down -100.00% over the past 3 years
- All-Time High Comparison
- AGL quarterly SG&A is currently -100.00% below its historical high of $79.25M set on
- 3-Year Low Comparison
- AGL quarterly SG&A vs 3-year low value is unknown
- Sector Comparison
- AGL quarterly SG&A is higher than 45.71% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly SG&A | $0.00 | -100.0% | -100.0% | -100.0% | -100.0% | |
| Annual SG&A | $268.91M | – | -5.9% | -37.1% | +118.9% | |
| TTM SG&A | -$6.63B | -2805.1% | -2521.2% | -3455.9% | -7289.8% | |
| Price | $0.99 | +0.5% | -73.1% | -95.2% | – | |
| Quarterly Operating Expenses | $52.11M | -7.2% | -15.5% | +1.2% | +63.2% | |
| Quarterly Operating Profit | -$127.18M | -9.7% | +3.7% | -338.5% | -1192.0% | |
| Quarterly D&A | $7.43M | +1.5% | +19.5% | +115.4% | +112.2% | |
| Quarterly Revenue | $1.44B | +2.9% | -1.1% | +106.6% | +359.0% |
Quarterly SG&A Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $65.96M | -100.0% | |
| 3Y | $79.25M | -100.0% | |
| 5Y | $79.25M | -100.0% | |
| All | $79.25M | -100.0% |
Quarterly SG&A Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $0.00 | N/A | |
| 3Y | $0.00 | N/A | |
| 5Y | $0.00 | N/A | |
| All | $0.00 | N/A |
Quarterly SG&A History
FAQ
What is the current quarterly SG&A of AGL?
As of today, AGL quarterly SG&A is $0.00
What is AGL quarterly SG&A most recent change?
AGL quarterly SG&A was down -100.00% on September 30, 2025
What is 1-year change in AGL quarterly SG&A?
AGL quarterly SG&A is down -100.00% year-over-year
How far is AGL quarterly SG&A from its all-time high?
AGL quarterly SG&A is currently -100.00% below its historical high of $79.25M set on June 30, 2023
How does AGL quarterly SG&A rank versus sector peers?
AGL quarterly SG&A is higher than 45.71% of companies in Healthcare sector
When is AGL next earnings release?
The next earnings release for AGL is on
TTM SG&A
-$6.63B$308.26M-4.88%
Summary
- Current Value
- As of today, AGL TTM SG&A is -$6.63B, down -4.88% on
- Historical Performance
- AGL TTM SG&A is down -2521.20% year-over-year, and down -3455.90% over the past 3 years
- All-Time High Comparison
- AGL TTM SG&A is currently -1102.95% below its historical high of -$551.19M set on an earlier date
- 3-Year Low Comparison
- AGL TTM SG&A is at its 3-year low
- Sector Comparison
- AGL TTM SG&A is higher than 6.00% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM SG&A | -$6.63B | -2805.1% | -2521.2% | -3455.9% | -7289.8% | |
| Annual SG&A | $268.91M | – | -5.9% | -37.1% | +118.9% | |
| Quarterly SG&A | $0.00 | -100.0% | -100.0% | -100.0% | -100.0% | |
| Price | $0.99 | +0.5% | -73.1% | -95.2% | – | |
| TTM Operating Profit | -$369.34M | +1.3% | -7.5% | -314.0% | -2081.6% | |
| TTM D&A | $28.12M | +4.5% | +21.6% | +108.2% | +171.8% | |
| TTM Revenue | $5.89B | -0.3% | +5.2% | +137.2% | +555.9% |
TTM SG&A Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | -$5.76B | N/A | -15.0% |
| 3Y | -$4.01B | N/A | -65.5% |
| 5Y | -$551.19M | N/A | -1103.0% |
| All | -$551.19M | N/A | -1103.0% |
TTM SG&A Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$6.63B | N/A | at low |
| 3Y | -$6.63B | N/A | at low |
| 5Y | -$6.63B | N/A | at low |
| All | -$6.63B | N/A | at low |
TTM SG&A History
FAQ
What is the current TTM SG&A of AGL?
As of today, AGL TTM SG&A is -$6.63B
What is AGL TTM SG&A most recent change?
AGL TTM SG&A was down -4.88% on September 30, 2025
What is 1-year change in AGL TTM SG&A?
AGL TTM SG&A is down -2521.20% year-over-year
How does AGL TTM SG&A rank versus sector peers?
AGL TTM SG&A is higher than 6.00% of companies in Healthcare sector
When is AGL next earnings release?
The next earnings release for AGL is on
Selling, General & Administrative Expenses Formula
SG&A = − − R&D
Data Sources & References
- AGL Official Website www.agilonhealth.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1831097/000162828025048839/0001628280-25-048839-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1831097/000162828025007721/0001628280-25-007721-index.htm
- AGL Profile on Yahoo Finance finance.yahoo.com/quote/AGL
- AGL Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/agl